Harrow, Inc. Reports Q3 2026 Financial Results

Harrow, Inc. reported third-quarter 2026 revenue of $99.3 million, exceeding the FactSet analyst consensus estimate of $98.6 million. The eyecare pharmaceutical company said results reflected ongoing performance in its branded products and ImprimisRx segments.